Cargando…
In silico prediction of novel therapeutic targets using gene–disease association data
BACKGROUND: Target identification and validation is a pressing challenge in the pharmaceutical industry, with many of the programmes that fail for efficacy reasons showing poor association between the drug target and the disease. Computational prediction of successful targets could have a considerab...
Autores principales: | Ferrero, Enrico, Dunham, Ian, Sanseau, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576250/ https://www.ncbi.nlm.nih.gov/pubmed/28851378 http://dx.doi.org/10.1186/s12967-017-1285-6 |
Ejemplares similares
-
Uncovering new disease indications for G-protein coupled receptors and their endogenous ligands
por: Freudenberg, Johannes M, et al.
Publicado: (2018) -
In Silico Identification of Genes Associated with Breast Cancer Progression and Prognosis and Novel Therapeutic Targets
por: Uchida, Shiro, et al.
Publicado: (2022) -
Connecting genetics and gene expression data for target prioritisation and drug repositioning
por: Ferrero, Enrico, et al.
Publicado: (2018) -
Systematic Analysis of Drug Targets Confirms Expression in Disease-Relevant Tissues
por: Kumar, Vinod, et al.
Publicado: (2016) -
Using regulatory genomics data to interpret the function of disease variants and prioritise genes from expression studies
por: Ferrero, Enrico
Publicado: (2018)